Biosimilars have the potential to generate significant savings for employers and health plans, yet many organizations struggle to translate that opportunity into action. What does it actually take to implement a successful Biosimilars First approach?
Join employer, policy, and healthcare leaders as they discuss real world strategies for increasing biosimilar adoption through plan design, purchaser engagement, stakeholder alignment, and policy innovation. The discussion will highlight both the opportunities and challenges associated with implementation and explore how employers can reduce specialty drug spending while maintaining quality, access, and employee satisfaction.
Attendees will gain actionable insights and practical considerations for evaluating biosimilars within their own benefits strategy.